Compared with the difference in efficacy between EGFR-TKIs alone and EGFR-TKIs combined with craniocerebral radiotherapy in EGFR mutant lung adenocarcinoma patients with brain metastasis. A propensity-score matched analysis

被引：0
|
作者：
Deng, G. [1 ]
Li, Z. [1 ]
机构：
[1] Shandong Univ, Shandong Canc Hosp, Jinan, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.1128
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1002P
引用
收藏
页码：S1012 / S1012
页数：1
相关论文
共 50 条
  • [1] Effect of EGFR-TKIs combined with craniocerebral radiotherapy on the prognosis of EGFR-mutant lung adenocarcinoma patients with brain metastasis: A propensity-score matched analysis
    Deng, Guangchuan
    Tan, Xiaojing
    Li, Yankang
    Zhang, Yingyun
    Wang, Qi
    Li, Jianbin
    Li, Zhenxiang
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [2] Effect of EGFR-TKIs Combined with Cerebral Radiotherapy on Prognosis of Patients with EGFR-Mutant Lung Adenocarcinoma with Brain Metastasis
    Deng, G.
    Li, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S164 - S164
  • [3] Combination therapy of brain radiotherapy and EGFR-TKIs is more effective than TKIs alone for EGFR-mutant lung adenocarcinoma patients with asymptomatic brain metastasis
    Chen, Yanxin
    Wei, Jianping
    Cai, Jing
    Liu, Anwen
    BMC CANCER, 2019, 19 (01)
  • [4] Combination therapy of brain radiotherapy and EGFR-TKIs is more effective than TKIs alone for EGFR-mutant lung adenocarcinoma patients with asymptomatic brain metastasis
    Yanxin Chen
    Jianping Wei
    Jing Cai
    Anwen Liu
    BMC Cancer, 19
  • [5] EGFR-TKIs compared with radiotherapy for patients of stage IV lung adenocarcinoma with EGFR mutation
    Wang, Y.
    Yu, W.
    Shi, J.
    Qiu, M.
    Jiang, N.
    Wang, Z.
    Yang, J.
    Song, M.
    Jia, Z.
    ANNALS OF ONCOLOGY, 2021, 32 : S976 - S976
  • [6] Evaluating the Efficacy of EGFR-TKIs Combined With Radiotherapy in Advanced Lung Adenocarcinoma Patients With EGFR Mutation: A Retrospective Study
    Wang, Yuxiang
    Yu, Wenjuan
    Shi, Jian
    Qiu, Rong
    Jiang, Nan
    Wang, Zhuofan
    Yang, Jie
    Jia, Zhongfei
    Song, Meng
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 21
  • [7] EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in EGFR-mutant NSCLC patients with multiple brain metastases
    Jiang, T.
    Zhou, C.
    ANNALS OF ONCOLOGY, 2019, 30
  • [8] EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in patients with EGFR-mutant NSCLC and multiple brain metastases
    Jiang, Tao
    Zhang, Yongchang
    Li, Xuefei
    Zhao, Chao
    Chen, Xiaoxia
    Su, Chunxia
    Ren, Shengxiang
    Yang, Nong
    Zhou, Caicun
    EUROPEAN JOURNAL OF CANCER, 2019, 121 : 98 - 108
  • [9] The content of mutant EGFR DNA correlates with response to EGFR-TKIs in lung adenocarcinoma patients with common EGFR mutations
    Hung, Ming-Szu
    Lung, Jr-Hau
    Lin, Yu-Ching
    Fang, Yu-Hung
    Hsieh, Meng-Jer
    Tsai, Ying-Huang
    MEDICINE, 2016, 95 (26)
  • [10] Bone metastasis reduces responsiveness to EGFR-TKIs in patients with EGFR-mutated advanced lung adenocarcinoma
    Zheng, X.
    Huang, C.
    Lin, G.
    ANNALS OF ONCOLOGY, 2018, 29
12345